Comparison of treatment modalities in pancreatic pseudocyst: A population based study

Table 1 Baseline characteristics of the study cohort, n (%)

	Percutaneous	Laparoscopic	Open Surgical	P value
	n = 347	n = 248	n = 107
Age				0.64
18-35	56 (16.1)	33 (13.3)	13 (12.1)
36-60	175 (50.4)	137 (55.2)	55 (51.4)
60 +	116 (33.4)	78 (31.5)	39 (36.4)
Sex				0.15
Male	220 (63.4)	158 (63.7)	66 (61.7)
Female	126 (36.3)	90 (36.3)	41 (38.3)
Race				0.53
White	224 (64.6)	169 (68.1)	70 (65.4)
Black	50 (14.4)	28 (11.3)	15 (14.0)
Hispanic	39 (11.2)	20 (8.1)	14 (13.1)
Asian-Pacific Islander	9 (2.6)	3 (1.2)	2 (1.9)
Other	14 (4.0)	13 (5.2)	2 (1.9)
Admission type				< 0.001
Emergency	318 (53.4)	212 (35.6)	65 (10.9)
Non-emergency	26 (25.0)	36 (34.6)	42 (40.4)
Hospital type				< 0.001
Urban teaching	280 (47.6)	227 (38.6)	81 (13.8)
Urban non-teaching	58 (60.4)	19 (19.8)	19 (19.8)
Rural	9 (50)	2 (11.1)	7 (38.9)
Primary payer				0.42
Medicare	111 (32.0)	62 (25.0)	35 (32.7)
Medicaid	71 (20.5)	57 (23.0)	24 (22.4)
Private	121 (34.9)	103 (41.5)	36 (33.6)
Other	44 (12.7)	26 (10.5)	12 (11.2)
Pancreatitis type				0.06
Acute	164 (47.3)	89 (35.9)	35 (32.7)
Acute on chronic	84 (24.2)	71 (28.6)	25 (23.4)
Chronic	38 (11.0)	36 (14.5)	17 (15.9)
Charlson Comorbidity index				0.77
0	126 (36.3)	103 (41.5)	45 (42.1)
1-2	189 (54.5)	123 (49.6)	56 (52.3)
3-4	30 (8.6)	21 (8.5)	6 (5.6)
≥ 5	2 (0.6)	1 (0.4)	0 (0.0)